Type / Class
Equity / Ordinary Shares, par value $0.000174 per share
Shares outstanding
55,803,824
Total 13F shares
16,966,777
Share change
-3,075,925
Total reported value
$87,370,000
Price per share
$5.15
Number of holders
28
Value change
-$80,695,326
Number of buys
20
Number of sells
13

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 207523101?
CUSIP 207523101 identifies CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13%
6,991,003
$169,392,000 30 Sep 2021
13F
FMR LLC
13F
Company
8.6%
4,818,188
$115,154,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
4.4%
2,450,060
$59,366,000 30 Sep 2021
13F
Boxer Capital, LLC
13F
Company
3.7%
2,081,323
$50,430,000 30 Sep 2021
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
2.1%
1,145,177
$27,370,000 30 Sep 2021
13F
Cormorant Asset Management, LP
13F
Company
0.9%
500,000
$11,950,000 30 Sep 2021
13F
RTW INVESTMENTS, LP
13F
Company
0.81%
450,000
$10,904,000 30 Sep 2021
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.72%
403,459
$9,567,000 30 Sep 2021
13F
Octagon Capital Advisors LP
13F
Company
0.58%
326,143
$7,795,000 30 Sep 2021
13F
Old Well Partners, LLC
13F
Company
0.22%
122,431
$2,967,000 30 Sep 2021
13F
ExodusPoint Capital Management, LP
13F
Company
0.03%
19,400
$470,000 30 Sep 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
19,283
$461,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
0.03%
17,527
$420,000 30 Sep 2021
13F
Parkwood LLC
13F
Company
0.03%
15,469
$375,000 30 Sep 2021
13F
Vident Investment Advisory, LLC
13F
Company
0.02%
10,851
$263,000 30 Sep 2021
13F
Invesco Ltd.
13F
Company
0.02%
9,059
$219,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
8,770
$212,000 30 Sep 2021
13F
Daiwa Securities Group Inc.
13F
Company
0.01%
6,069
$147,000 30 Sep 2021
13F
CITIGROUP INC
13F
Company
0%
998
$24,000 30 Sep 2021
13F
UBS Group AG
13F
Company
0%
435
$11,000 30 Sep 2021
13F

Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) as of Q4 2021

As of 31 Dec 2021, Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,966,777 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., FMR LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Deep Track Capital, LP, RTW INVESTMENTS, LP, JANUS HENDERSON GROUP PLC, BANK OF AMERICA CORP /DE/, Octagon Capital Advisors LP, and Ikarian Capital, LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
20
Q4 2021 holders
28
Holder diff
8
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.